Allworth Financial LP boosted its holdings in AMETEK, Inc. (NYSE:AME – Free Report) by 3,827.6% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 20,070 shares of the technology company’s stock after buying an additional 19,559 shares during the period. Allworth Financial LP’s holdings in AMETEK were worth $3,632,000 as of its most recent SEC filing.
Other hedge funds also recently modified their holdings of the company. Banco Santander S.A. increased its holdings in AMETEK by 20.8% in the first quarter. Banco Santander S.A. now owns 45,365 shares of the technology company’s stock valued at $7,809,000 after purchasing an additional 7,799 shares during the last quarter. M.D. Sass LLC increased its stake in AMETEK by 2.1% in the first quarter. M.D. Sass LLC now owns 366,994 shares of the technology company’s stock valued at $63,174,000 after purchasing an additional 7,666 shares in the last quarter. Raiffeisen Bank International AG raised its holdings in AMETEK by 16.5% in the first quarter. Raiffeisen Bank International AG now owns 44,647 shares of the technology company’s stock worth $7,607,000 after purchasing an additional 6,318 shares during the period. FORA Capital LLC boosted its position in shares of AMETEK by 103.5% during the first quarter. FORA Capital LLC now owns 5,314 shares of the technology company’s stock worth $915,000 after purchasing an additional 2,703 shares in the last quarter. Finally, Jump Financial LLC grew its holdings in shares of AMETEK by 462.4% in the 1st quarter. Jump Financial LLC now owns 70,256 shares of the technology company’s stock valued at $12,094,000 after buying an additional 57,763 shares during the period. 87.43% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
A number of research analysts have issued reports on AME shares. Truist Financial boosted their target price on AMETEK from $219.00 to $229.00 and gave the company a “buy” rating in a research note on Wednesday, October 8th. Royal Bank Of Canada boosted their price objective on AMETEK from $212.00 to $229.00 and gave the company an “outperform” rating in a research report on Friday, October 31st. Wall Street Zen upgraded shares of AMETEK from a “hold” rating to a “buy” rating in a report on Saturday, November 1st. DA Davidson boosted their price objective on shares of AMETEK from $210.00 to $215.00 and gave the company a “buy” rating in a research report on Friday, August 1st. Finally, Mizuho increased their target price on AMETEK from $212.00 to $225.00 and gave the stock an “outperform” rating in a report on Friday, August 1st. Eight analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $211.00.
Insider Activity
In other news, insider Ronald J. Oscher sold 26,290 shares of AMETEK stock in a transaction that occurred on Friday, October 31st. The stock was sold at an average price of $200.05, for a total transaction of $5,259,314.50. Following the completion of the transaction, the insider directly owned 40,226 shares in the company, valued at approximately $8,047,211.30. The trade was a 39.52% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.57% of the stock is currently owned by insiders.
AMETEK Trading Up 0.0%
Shares of AMETEK stock opened at $197.72 on Thursday. The stock has a market cap of $45.51 billion, a P/E ratio of 31.84, a P/E/G ratio of 2.64 and a beta of 1.12. The company has a quick ratio of 1.04, a current ratio of 1.63 and a debt-to-equity ratio of 0.15. AMETEK, Inc. has a 12-month low of $145.02 and a 12-month high of $204.15. The business’s 50 day moving average is $188.68 and its 200-day moving average is $182.80.
AMETEK (NYSE:AME – Get Free Report) last posted its quarterly earnings results on Thursday, October 30th. The technology company reported $1.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.76 by $0.13. The firm had revenue of $1.89 billion for the quarter, compared to analyst estimates of $1.81 billion. AMETEK had a net margin of 20.60% and a return on equity of 16.53%. The company’s quarterly revenue was up 10.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.66 earnings per share. AMETEK has set its Q4 2025 guidance at 1.900-1.950 EPS. FY 2025 guidance at 7.320-7.370 EPS. Equities research analysts predict that AMETEK, Inc. will post 7.15 earnings per share for the current fiscal year.
AMETEK Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 19th. Shareholders of record on Friday, December 5th will be paid a $0.31 dividend. The ex-dividend date is Friday, December 5th. This represents a $1.24 annualized dividend and a yield of 0.6%. AMETEK’s dividend payout ratio is currently 19.56%.
AMETEK Company Profile
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
Featured Articles
- Five stocks we like better than AMETEK
- 3 Healthcare Dividend Stocks to Buy
- Rare Earth Stocks: The Truce That Isn’t a Truce
- The 3 Best Retail Stocks to Shop for in August
- Carving Up Profits: 3 Food Stocks on the Thanksgiving Table
- Why Are These Companies Considered Blue Chips?
- C3.ai’s Reset: Why New Leadership Could Spark a Turnaround
Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AME – Free Report).
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.
